Vivelle Estradiol Transdermal System Trademark Details

Vivelle Estradiol Transdermal System was registered on Tuesday, September 9, 1997 and is currently owned by Novartis Corporation under the registration number 2095515 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 17 years ago on Tuesday, January 2, 2007, according to the United State Patent & Trademark Office

Word Mark	Vivelle Estradiol Transdermal System
Status	Alive Registered 800 — Registered and Renewed

Serial Number	74583529
Registration Number	2095515
Status Date	Tuesday, January 2, 2007
Filing Date	Tuesday, January 2, 2007
Registration Date	Tuesday, September 9, 1997
Attorney	Maury M. Tepper, III

Correspondent

Maury M. Tepper, III
Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh NC 27609

Case File Statements

Disclaimer with Predetermined Text	"Estradiol Transdermal System"
Goods & Services	Transderm Estradiol Patch for Hormone Deficiency

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	006, 018, 044, 046, 051, 052
Status	6 — Active
Status Date	Friday, January 27, 1995
First Use Anywhere	Friday, February 16, 1996
First Use In Commerce	Friday, February 16, 1996
Primary Code	005

Trademark Timeline

Oct 07 1994

Trademark application filed with USPTO
Feb 22 1995

Assigned To Examiner
Feb 23 1995

Non-Final Action Mailed
Mar 27 1995

Correspondence Received In Law Office
May 11 1995

Approved For Pub - Principal Register
Aug 04 1995

Notice of Publication
Sep 05 1995

Published For Opposition
Nov 28 1995

Noa Mailed - Sou Required From Applicant
Feb 16 1996

First use anywhere for the mark
Feb 16 1996

First use in commerce for the mark
May 23 1996

Extension 1 Filed
Aug 22 1996

Extension 1 Granted
Nov 25 1996

Extension 2 Filed
Jan 13 1997

Extension 2 Granted
May 27 1997

Use Amendment Filed
Jun 24 1997

Statement of Use Processing Complete
Jun 27 1997

Assigned To Examiner
Jul 05 1997

Allowed Principal Register - Sou Accepted
Sep 09 1997

Registered-Principal Register
Sep 09 1997

Trademark officially registered with the USPTO
Mar 10 2003

Registered - Sec. 8 (6-Yr) Filed
Mar 10 2003

Teas Section 8 & 9 Received
Jun 16 2003

Registered - Sec. 8 (6-Yr) Accepted
Nov 18 2004

Paper Received
Dec 04 2004

Teas Change of Correspondence Received
Oct 18 2006

Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
Oct 18 2006

Teas Section 8 & 9 Received
Dec 19 2006

Assigned To Paralegal
Jan 02 2007

Registered and Renewed (first Renewal - 10 Yrs)
Jan 02 2007

Registered - Sec. 8 (10-Yr) Accepted/sec. 9 Granted
Mar 05 2007

Case File In Ticrs
Jun 27 2009

Teas Change of Correspondence Received
Jun 27 2009

Teas Change of Correspondence Received
Sep 09 2016

Courtesy Reminder - Sec. 8 (10-Yr)/sec. 9 E-Mailed

Vivelle Estradiol Transdermal System Trademark Details

Correspondent

Case File Statements

Classifications

Trademark Timeline

You must be signed in to print.

Once signed in, look for the PDF button.